Founder interview
“What challenge does Dynamic42 solve? What is our vision?” or “What have been our greatest successes?” are just some of the questions we answered in the interview with bionity and analytica-world. Read the complete interview at analytica-world or bionity.
In addition, we at bionity can now also be found in the start-up directory:
Read now more News:
News, News-Cancer
Press Release | Dynamic42 and EPO Close the Gap in Brain Cancer Research
Dynamic42 GmbH and EPO Experimental Pharmacology & Oncology are collaborating to advance brain cancer research by integrating organ-on-chip technologies into preclinical drug development.
Read MoreNews, News-TEER
Press Release | Setting a New Benchmark in Functional Barrier Analysis
Dynamic42 announces the launch of its DynamicOrgan® TEER-Sensor System enabling real-time, non-invasive monitoring of barrier integrity within an organ-on-chip model.
Read MoreNews
Press Release | Dynamic42 gewinnt Life-Science-Experten Wolfgang Kintzel als strategischen Berater
Dynamic42 GmbH hat den international erfahrenen Manager Wolfgang Kintzel als strategischen Berater gewonnen.
Read More

